BRIEF published on 02/17/2025 at 10:05, 1 month ago Sartorius publie son rapport annuel 2024 Sartorius Performance Financière Sciences De La Vie Rapport Annuel 2024 Solutions De Bioprocédés
BRIEF published on 02/17/2025 at 10:05, 1 month ago Sartorius Releases 2024 Annual Report Financial Performance Life Sciences Sartorius Annual Report 2024 Bioprocess Solutions
PRESS RELEASE published on 02/17/2025 at 10:00, 1 month ago Sartorius releases Annual Report for 2024 Sartorius releases Annual Report for 2024. The life science company showcases financial performance and future outlook. For more details, visit the provided link Financial Performance Annual Report Sartorius 2024 Life Science
BRIEF published on 02/07/2025 at 15:53, 1 month 10 days ago Sartorius AG propose un dividende pour 2024 Exercice 2024 Assemblée Générale Annuelle Actualités Financières Proposition De Dividende Sartorius SA
BRIEF published on 02/07/2025 at 15:53, 1 month 10 days ago Sartorius AG Proposes Dividend for 2024 Annual General Meeting Financial News Dividend Proposal Sartorius AG 2024 Fiscal Year
PRESS RELEASE published on 02/07/2025 at 15:48, 1 month 10 days ago The Supervisory Board of Sartorius AG proposes a dividend of 0.74 euros per preference share The Supervisory Board of Sartorius AG proposes a dividend of 0.74 euros per preference share for fiscal 2024. Dividend payment on April 1, 2025 Annual General Meeting Dividend Supervisory Board Sartorius AG Preference Share
BRIEF published on 01/28/2025 at 07:05, 1 month 21 days ago Sartorius annonce une clôture positive pour l'exercice 2024 Chiffre D'affaires Exercice 2024 Prévisions De Croissance Sartorius SA Marge Bénéficiaire
BRIEF published on 01/28/2025 at 07:05, 1 month 21 days ago Sartorius Reports Positive Closing for Fiscal 2024 Fiscal 2024 Sales Revenue Sartorius AG Growth Forecast Profit Margin
PRESS RELEASE published on 01/28/2025 at 07:00, 1 month 21 days ago Sartorius closes fiscal 2024 with very good fourth quarter and positive trend; full-year guidance achieved Sartorius closes fiscal 2024 with stable sales revenue and positive trend, meeting full-year guidance. Order intake up; cautiously optimistic outlook for 2025 Fiscal 2024 Sartorius Sales Revenue Full-year Guidance Outlook 2025
BRIEF published on 12/06/2024 at 18:26, 3 months 11 days ago Michael Grosse Appointed as New CEO of Sartorius AG CEO Transition Sartorius AG Biopharma Industry Joachim Kreuzburg Michael Grosse
Published on 03/18/2025 at 02:00, 5 hours 39 minutes ago Gold Mountain Reports its Interim Q4 2025 Financial and Operating Results
Published on 03/18/2025 at 01:00, 6 hours 39 minutes ago Gold Mountain Announces Change in Financial Year-End
Published on 03/17/2025 at 23:15, 8 hours 24 minutes ago Presentation to Swiss Mining Institute Conference
Published on 03/17/2025 at 22:00, 9 hours 39 minutes ago Tecogen Announces Fourth Quarter and Year-End 2024 Results
Published on 03/17/2025 at 21:30, 10 hours 9 minutes ago Commerce Resources Announces Change in Management
Published on 03/18/2025 at 07:00, 38 minutes ago Springer Nature achieves revenue and profit targets and projects further growth for 2025
Published on 03/18/2025 at 07:00, 38 minutes ago DKSH Technology Acquires Taqkey Science and Quantum Biotech, Two Technology Distribution Companies in Taiwan
Published on 03/18/2025 at 07:00, 38 minutes ago PolyPeptide publishes invitation to the annual General Meeting 2025
Published on 03/18/2025 at 07:00, 38 minutes ago HomeToGo extends Co-founder & CEO Dr. Patrick Andrae’s contract by four years
Published on 03/18/2025 at 07:01, 38 minutes ago bioMérieux receives FDA 510(k) Clearance for its VITEK® COMPACT PRO, a new ID/AST system to fight against antimicrobial resistance
Published on 03/18/2025 at 07:00, 39 minutes ago Peugeot Invest cède avec succès la moitié de sa participation dans SPIE
Published on 03/18/2025 at 07:00, 39 minutes ago Peugeot Invest successfully sold half of its stake in SPIE
